Literature DB >> 19636265

Rationale for IL-1beta targeted therapy for ischemia-reperfusion induced pulmonary and other complications in sickle cell disease.

Alan A Wanderer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19636265     DOI： 10.1097/MPH.0b013e3181acd89d

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


× No keyword cloud information.
  7 in total

Review 1.  Sterile inflammatory responses mediated by the NLRP3 inflammasome.

Authors:  Suzanne L Cassel; Fayyaz S Sutterwala
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

2.  Iron, inflammation, and early death in adults with sickle cell disease.

Authors:  Eduard J van Beers; Yanqin Yang; Nalini Raghavachari; Xin Tian; Darlene T Allen; James S Nichols; Laurel Mendelsohn; Sergei Nekhai; Victor R Gordeuk; James G Taylor; Gregory J Kato
Journal:  Circ Res       Date:  2014-11-06       Impact factor: 17.367

3.  Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.

Authors:  Chelsea A Embry; Luigi Franchi; Gabriel Nuñez; Thomas C Mitchell
Journal:  Sci Signal       Date:  2011-05-03       Impact factor: 8.192

Review 4.  Inflammasome and IL-1beta-mediated disorders.

Authors:  Hal M Hoffman; Alan A Wanderer
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

5.  High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia.

Authors:  Igor F Domingos; Diego A Pereira-Martins; Marcondes J V C Sobreira; Romulo T D Oliveira; Adekunle E Alagbe; Carolina Lanaro; Dulcineia M Albuquerque; Maria H S L Blotta; Aderson S Araujo; Fernando F Costa; Antonio R Lucena-Araujo; Maria F Sonati; Marcos A C Bezerra; Magnun N N Santos
Journal:  Ann Hematol       Date:  2020-03-05       Impact factor: 3.673

Review 6.  Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.

Authors:  Charles A Dinarello; Anna Simon; Jos W M van der Meer
Journal:  Nat Rev Drug Discov       Date:  2012-08       Impact factor: 84.694

7.  Transgenic sickle cell disease mice have high mortality and dysregulated immune responses after vaccination.

Authors:  Steven M Szczepanek; Eric R Secor; Sonali J Bracken; Linda Guernsey; Ektor Rafti; Adam Matson; Roger S Thrall; Biree Andemariam
Journal:  Pediatr Res       Date:  2013-05-31       Impact factor: 3.756
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.